Photo of Meredith F. Reeves

Meredith is a managing associate in the Employee Benefits & Executive Compensation group. She has extensive experience advising health plans on a wide range of issues, including counseling clients on ERISA and Affordable Care Act compliance, advising on plan fiduciary processes and documentation, and drafting and reviewing service contracts and amendments. She also assists with documentation related to pharmacy benefit management (PBM) services and ensures that plans are compliant with relevant PBM laws and regulations.

On January 17, 2025, the ERISA Industry Committee (“ERIC”) filed a lawsuit, The ERISA Industry Committee v. United States Department of Health and Human Services et al. challenging the final Mental Health Parity and Addiction Equity Act (“MHPAEA”) rule published by the Departments of Labor, Treasury, and Health and Human Services (the “Departments”) in

Earlier this year, current and former participants of two ERISA-governed health plans filed complaints alleging the same novel legal theory: that plan fiduciaries violated ERISA by mismanaging the plan’s prescription drug benefits.  In both complaints, plaintiffs alleged that the mismanagement was caused in part by the plans paying excessive and unreasonable fees to their respective

Imagine you’re a plan administrator who receives an angry letter from an out-of-network provider.  The letter explains that before treating a plan participant, the provider called to confirm the participant’s eligibility for out-of-network coverage and to authorize treatments at certain rates under the plan.  Now that treatment has been rendered, the provider is demanding payment